If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQG.L Regulatory News (IQG)

  • There is currently no data for IQG

Trading Update

3 Jul 2015 07:00

RNS Number : 0730S
Ubisense Group PLC
03 July 2015
 

3 July 2015

 

Ubisense Group PLC (the "Company")

 

Trading Update

 

Ubisense ("Ubisense" or the "Company") (LON:UBI), a market leader in enterprise location intelligence solutions, announces an update on current trading following the close of the Company's first half ended 30 June 2015.

 

The Company's seasonality profile has typically seen it sign the majority of its higher margin Solutions revenues in the second and fourth quarters. In addition to the anticipated reduction in lower margin Services revenues and the previously announced slippage of two major contracts into H2, we have now seen further delays in signature of certain contracts, with the result that Solutions revenue for the first half will now be some way short of that achieved in the first half of 2014.

 

Although the majority of the contracts which have slipped are expected to be closed during the second half, the Board believes it is prudent to plan on the basis that the H1 revenue shortfall is unlikely to be recovered in full in the second half of 2015. The Company's gross margin is however expected to be significantly higher in the second half of the year than the first half driven by the anticipated conversion of our Solutions opportunities increasing the mix of higher margin licence sales. Additionally, a review of the Ubisense business and its costs has led the Board to conclude that a restructuring of its operations is required to drive operational profitability.

 

As previously announced, Peter Harverson has been acting as Vice Chairman to provide senior oversight and leadership to the sales team on an interim basis. Under his guidance, the restructuring activity, addressing both overhead costs and sales effectiveness in certain smaller markets, will incur one-off charges and is expected to deliver significant ongoing savings and mitigate the impact of the revenue shortfall on the full year operating result. Much of this restructuring is already underway and expected to be substantially completed by the time we announce our half-year results.

 

 

 

Enquiries:

 

Ubisense Group plc +44 (0) 1223 535170

Richard Green, Chief Executive

Numis Securities Limited +44 (0) 20 7260 1000

Rupert Krefting (Corporate Broking)

Simon Willis, James Lillywhite (Corporate Finance)

 

About Ubisense

Ubisense (AIM: UBI), a global leader in Enterprise Location Intelligence solutions, helps manufacturing, communications and utility companies improve operational efficiency and boost profitability. Ubisense location intelligence systems bring clarity to complexity, enabling customers to revolutionise their operational effectiveness in a measurable way. Founded in 2002, Ubisense is headquartered in Cambridge, England, with offices in North America, France, Germany, Japan, Korea and Singapore. For more information visit: www.ubisense.net.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKBDKOBKDNOK
Date   Source Headline
15th May 202412:44 pmRNSForm 8.3 - IQGeo Group plc
15th May 202412:05 pmRNSForm 8.3 - IQGeo Group plc
15th May 202411:41 amRNSForm 8.3 - [IQGeo Group plc ]
15th May 202411:09 amRNSForm 8.3 - IQGeo Group PLC
15th May 202410:47 amRNSForm 8.5 (EPT/NON-RI)
15th May 202410:00 amPRNForm 8.3 - IQGeo Group plc
15th May 20249:10 amRNSRule 2.9 Announcement and TVR
14th May 20243:38 pmRNSForm 8.3 - IQGEO Group plc
14th May 202411:55 amRNSForm 8.3 - IQGeo Group plc
14th May 202410:28 amRNSRecommended Cash Acquisition
3rd May 20247:00 amRNSTotal Voting Rights
30th Apr 202411:15 amRNSHolding(s) in Company
16th Apr 20247:00 amRNSPosting of the Annual Report and Notice of AGM
25th Mar 202411:15 amRNSHolding(s) in Company
20th Mar 20248:27 amRNSFinal results for the year ended 31 December 2023
15th Mar 202410:00 amRNSNotice of Results and Investor Presentation
8th Mar 20248:15 amRNSHolding(s) in Company
4th Mar 20249:22 amRNSTotal Voting Rights
31st Jan 202410:00 amRNSBlock Admission Application
19th Jan 20244:40 pmRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSTrading Update
8th Jan 20247:00 amRNSTop 10 US telecom operator selects IQGeo
28th Dec 20239:15 amRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSTop 5 telecom operator expands IQGeo deployment
19th Dec 20237:00 amRNSDirector/PDMR Shareholding
18th Dec 202310:00 amRNSHolding(s) in Company
15th Dec 20232:15 pmRNSExercise of Options and Total Voting Rights
12th Dec 20232:00 pmRNSExercise of Options and Total Voting Rights
11th Dec 202310:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSTier 1 US utility selects IQGeo
4th Dec 20235:03 pmRNSExercise of Options and Total Voting Rights
4th Dec 20235:00 pmRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSCapital Markets Day
27th Nov 20231:30 pmRNSDirector/PDMR Shareholding
13th Nov 20233:00 pmRNSExercise of Options and Total Voting Rights
1st Nov 20237:00 amRNSCapital Markets Day and Product Strategy Update
29th Sep 20237:00 amRNSSignificant new European customer win
25th Sep 20237:00 amRNSHalf-year Report
20th Sep 20237:00 amRNSLarge US and European Operator Selects IQGeo
4th Sep 20231:15 pmRNSNotice of Interim Results & Investor Presentation
29th Aug 20237:00 amRNSDirector/PDMR Shareholding
22nd Aug 20234:00 pmRNSExercise of Options and Total Voting Rights
21st Aug 20234:31 pmRNSDirector/PDMR Shareholding
18th Aug 20235:30 pmRNSExercise of Options and Total Voting Rights
14th Aug 20237:00 amRNSExercise of Options and Total Voting Rights
11th Aug 20235:30 pmRNSDirector/PDMR Shareholding
4th Aug 20235:00 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSDirector/PDMR Shareholding
28th Jul 20236:15 pmRNSExercise of Options and Total Voting Rights
24th Jul 20237:00 amRNSDirector/PDMR Shareholding - Grant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.